Literature DB >> 24695072

Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials.

Michelle L Davis1, Mark B Powers2, Pamela Handelsman3, Johnna L Medina2, Michael Zvolensky4, Jasper A J Smits2.   

Abstract

Narrative reviews conclude that behavioral therapies (BTs) produce better outcomes than control conditions for cannabis use disorders (CUDs). However, the strength and consistency of this effect has not been directly empirically examined. The present meta-analysis combined multiple well-controlled studies to help clarify the overall impact of behavioral interventions in the treatment of CUDs. A comprehensive literature search produced 10 randomized controlled trials (RCTs; n = 2,027) that were included in the final analyses. Analyses indicated an effect of BTs (including contingency management, relapse prevention, and motivational interviewing, and combinations of these strategies with cognitive behavioral therapy) over control conditions (including waitlist [WL], psychological placebo, and treatment as usual) across pooled outcomes and time points (Hedges' g = 0.44). These results suggest that the average patient receiving a behavioral intervention fared better than 66% of those in the control conditions. BT also outperformed control conditions when examining primary outcomes alone (frequency and severity of use) and secondary outcomes alone (psychosocial functioning). Effect sizes were not moderated by inclusion of a diagnosis (RCTs including treatment-seeking cannabis users who were not assessed for abuse or dependence vs. RCTs including individuals diagnosed as dependent), dose (number of treatment sessions), treatment format (either group vs. individual treatment or in-person vs. non-in-person treatment), sample size, or publication year. Effect sizes were significantly larger for studies that included a WL control comparison versus those including active control comparisons, such that BT significantly outperformed WL controls but not active control comparisons.
© The Author(s) 2014.

Entities:  

Keywords:  CBT; behavioral therapies; cannabis; cognitive behavioral therapy; marijuana; meta-analysis; review; substance use disorder

Mesh:

Year:  2014        PMID: 24695072      PMCID: PMC4429893          DOI: 10.1177/0163278714529970

Source DB:  PubMed          Journal:  Eval Health Prof        ISSN: 0163-2787            Impact factor:   2.651


  45 in total

1.  Exercise activates the endocannabinoid system.

Authors:  P B Sparling; A Giuffrida; D Piomelli; L Rosskopf; A Dietrich
Journal:  Neuroreport       Date:  2003-12-02       Impact factor: 1.837

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Brief treatments for cannabis dependence: findings from a randomized multisite trial.

Authors: 
Journal:  J Consult Clin Psychol       Date:  2004-06

Review 4.  Endocannabinoids and exercise.

Authors:  A Dietrich; W F McDaniel
Journal:  Br J Sports Med       Date:  2004-10       Impact factor: 13.800

5.  Treatment of marijuana dependence: preliminary results.

Authors:  R A Roffman; R S Stephens; E E Simpson; D L Whitaker
Journal:  J Psychoactive Drugs       Date:  1988 Jan-Mar

6.  Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis.

Authors:  L Degenhardt; W Hall; M Lynskey
Journal:  Addiction       Date:  2001-11       Impact factor: 6.526

Review 7.  Treatment of marijuana dependence: a review of the literature.

Authors:  Aimee L McRae; Alan J Budney; Kathleen T Brady
Journal:  J Subst Abuse Treat       Date:  2003-06

8.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

9.  Marijuana withdrawal in humans: effects of oral THC or divalproex.

Authors:  Margaret Haney; Carl L Hart; Suzanne K Vosburg; Jennifer Nasser; Andrew Bennett; Carlos Zubaran; Richard W Foltin
Journal:  Neuropsychopharmacology       Date:  2004-01       Impact factor: 7.853

10.  Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Wilson M Compton; Bridget F Grant; James D Colliver; Meyer D Glantz; Frederick S Stinson
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

View more
  35 in total

1.  Distinguishing subpopulations of marijuana users with latent profile analysis.

Authors:  Matthew R Pearson; Adrian J Bravo; Bradley T Conner
Journal:  Drug Alcohol Depend       Date:  2016-11-23       Impact factor: 4.492

2.  Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users.

Authors:  Hollis C Karoly; Joseph P Schacht; Joanna Jacobus; Lindsay R Meredith; Charles T Taylor; Susan F Tapert; Kevin M Gray; Lindsay M Squeglia
Journal:  Drug Alcohol Depend       Date:  2019-05-14       Impact factor: 4.492

3.  Cannabis use history and characteristics of quit attempts: a comparison study of treatment-seeking and non-treatment-seeking cannabis users.

Authors:  Lauren R Pacek; Ryan Vandrey
Journal:  Exp Clin Psychopharmacol       Date:  2014-08-25       Impact factor: 3.157

Review 4.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

5.  Mental disorder comorbidity and treatment utilization.

Authors:  Craig Rodriguez-Seijas; Nicholas R Eaton; Malki Stohl; Pia M Mauro; Deborah S Hasin
Journal:  Compr Psychiatry       Date:  2017-02-09       Impact factor: 3.735

Review 6.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

Review 7.  [Cannabis-induced disorders].

Authors:  M Soyka; U Preuss; E Hoch
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

8.  Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.

Authors:  Robert Miranda; Hayley Treloar; Alexander Blanchard; Alicia Justus; Peter M Monti; Thomas Chun; Robert Swift; Jennifer W Tidey; Chad J Gwaltney
Journal:  Addict Biol       Date:  2016-01-11       Impact factor: 4.280

9.  Passion for Marijuana Use Mediates the Relations between Refusal Self-Efficacy and Marijuana Use and Associated Consequences.

Authors:  Alan K Davis; Brooke J Arterberry
Journal:  J Psychoactive Drugs       Date:  2019-04-04

10.  Using Ecological Momentary Assessment to Identify Mechanisms of Change: An Application From a Pharmacotherapy Trial With Adolescent Cannabis Users.

Authors:  Hayley Treloar Padovano; Robert Miranda
Journal:  J Stud Alcohol Drugs       Date:  2018-03       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.